Wednesday, March 05, 2025 | 11:03 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Home / Companies / News / Aventis Pharma Q3 net rises 57%

Aventis Pharma Q3 net rises 57%

BS 200 Scorecard

Image

Our Corporate Bureau Mumbai
Last Updated : Jan 28 2013 | 2:26 AM IST
 Total income (net of excise) during the reporting quarter increased to Rs 168.90 crore, from Rs 162.30 crore in SQ-02.

 

More From This Section

Sebi free to seize properties of Sahara Group companies: SC

Sebi free to seize properties of Sahara Group companies: SC

Times Group signs distribution deal for TV channels with MSM Discovery

Times Group signs distribution deal for TV channels with MSM Discovery

GMR gets some relief as AI settles part of its dues

GMR gets some relief as AI settles part of its dues

Raters can't offer fee-based services beyond ratings, research: Sebi

Raters can't offer fee-based services beyond ratings, research: Sebi

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 18 2003 | 12:00 AM IST

Explore News

Stock Market LIVESA vs NZ LIVE SCOREStocks to Watch TodayMarket TodayGold Silver Price TodayVivo T4x launch TodayLatest News LIVEDelhi School EWS admissions result 2025Nothing Phone 3a Pro ReviewApple ipad air m3 price
HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2025 Business Standard Private Ltd. All rights reserved
LinkedIN Icon